enVVeno Medical Corporation

Historical 13F Holders

Symbol
NVNO
CUSIP
29415J106
All holders as of
Q4 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 29415J106 since 12/18/2024, newest first.

Filer % of Class Filed
Perceptive Advisors LLC 13G/A Amendment 6
10.0% 2/17/2026
Event 12/31/2025
Thomas A. Satterfield, Jr. 13G 9.0% 11/19/2025
Event 11/14/2025
Nantahala Capital Management, LLC 13G/A Amendment 2
3.5% 11/14/2025
Event 9/30/2025
Kingdon Capital Management, L.L.C. 13G
7.1% 9/9/2025
Event 9/2/2025
Nantahala Capital Management, LLC 13G/A Amendment 1
7.1% 11/14/2024
Event 9/30/2024

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q4 37 6.56 M $2.10 M
2025 Q3 41 6.16 M $5.60 M
2025 Q2 39 5.09 M $20.3 M
2025 Q1 35 3.65 M $9.61 M
2024 Q4 39 4.26 M $12.9 M
2024 Q3 41 5.21 M $17.5 M
2024 Q2 32 3.86 M $20.3 M
2024 Q1 38 3.84 M $20.9 M
2023 Q4 37 5.23 M $26.9 M
2023 Q3 26 1.93 M $10.4 M
2023 Q2 26 1.92 M $5.90 M
2023 Q1 19 1.81 M $8.50 M
2022 Q4 26 1.68 M $8.57 M
2022 Q3 26 2.19 M $13.7 M
2022 Q2 24 2.15 M $8.11 M
2022 Q1 25 2.04 M $13.0 M
2021 Q4 30 2.86 M $18.9 M
2021 Q3 1 12.2 k $127 k